(Q38064230)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23201558%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

review article

1 reference

title

Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theiler's virus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23201558%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

0 references

1 reference

Francisco Carrillo-Salinas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23201558%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Leyre Mestre

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23201558%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Ana Feliú

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23201558%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Miriam Mecha

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23201558%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Carmen Guaza

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23201558%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

publication date

29 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23201558%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

published in

Progress in Neurobiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23201558%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

101-102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23201558%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

46-64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23201558%20AND%20SRC:MED&resulttype=core&format=json

Autoimmune encephalomyelitis ameliorated by AMPA antagonists

19 February 2020

cites work

1 reference

12 December 2020

[Guidelines on the appropriate use of animal models for developing therapies in multiple sclerosis]

1 reference

12 December 2020

Substrain differences reveal novel disease-modifying gene candidates that alter the clinical course of a rodent model of multiple sclerosis

1 reference

12 December 2020

Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus

1 reference

12 December 2020

Human antibodies accelerate the rate of remyelination following lysolecithin-induced demyelination in mice

1 reference

12 December 2020

Interaction of immune and central nervous systems: contribution of anti-viral Thy-1+ cells to demyelination induced by coronavirus JHM

1 reference

12 December 2020

Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infection

1 reference

12 December 2020

Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis

1 reference

12 December 2020

Exacerbations of multiple sclerosis in patients treated with gamma interferon

1 reference

12 December 2020

A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis

1 reference

12 December 2020

OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS

1 reference

12 December 2020

Genetically dominant spinal cord repair in a murine model of chronic progressive multiple sclerosis.

1 reference

12 December 2020

Gamma interferon is critical for neuronal viral clearance and protection in a susceptible mouse strain following early intracranial Theiler's murine encephalomyelitis virus infection.

1 reference

12 December 2020

Pathogenesis of murine coronavirus in the central nervous system

1 reference

12 December 2020

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

1 reference

12 December 2020

Minus-strand RNA synthesis in the spinal cords of mice persistently infected with Theiler's virus

1 reference

12 December 2020

Publication guidelines for refereeing and reporting on animal use in experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Quantitative, not qualitative, differences in CD8(+) T cell responses to Theiler's murine encephalomyelitis virus between resistant C57BL/6 and susceptible SJL/J mice

1 reference

12 December 2020

Contribution of T cells to mortality in neurovirulent Sindbis virus encephalomyelitis

1 reference

12 December 2020

Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody

1 reference

12 December 2020

Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel

1 reference

12 December 2020

DA strain of Theiler's murine encephalomyelitis virus induces demyelination in nude mice

1 reference

12 December 2020

Purkinje cell loss in experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination

1 reference

12 December 2020

Monoclonal antibody defines determinant between Theiler's virus and lipid-like structures

1 reference

12 December 2020

Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis

1 reference

12 December 2020

The relevance of animal models in multiple sclerosis research

1 reference

12 December 2020

Promotion of remyelination by immunoglobulins: implications for the treatment of multiple sclerosis

1 reference

12 December 2020

The balance between persistent virus infection and immune cells determines demyelination.

1 reference

12 December 2020

Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors

1 reference

12 December 2020

Preservation of neurologic function during inflammatory demyelination correlates with axon sparing in a mouse model of multiple sclerosis

1 reference

12 December 2020

Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis

1 reference

12 December 2020

Targeting inflammatory demyelinating lesions to sites of Wallerian degeneration.

1 reference

12 December 2020

Direct comparison of demyelinating disease induced by the Daniel's strain and BeAn strain of Theiler's murine encephalomyelitis virus

1 reference

12 December 2020

Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor alpha

1 reference

12 December 2020

Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis

1 reference

12 December 2020

Role of the immune response in Sindbis virus-induced paralysis of SJL/J mice

1 reference

12 December 2020

Immunoglobulins promote remyelination in the central nervous system

1 reference

12 December 2020

High frequency of human herpesvirus 6 DNA in multiple sclerosis plaques isolated by laser microdissection.

1 reference

12 December 2020

Neuropathogenesis of Theiler's murine encephalomyelitis virus infection, an animal model for multiple sclerosis

1 reference

12 December 2020

Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion

1 reference

12 December 2020

Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice

1 reference

12 December 2020

The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation

1 reference

12 December 2020

Expression of viral and myelin gene transcripts in a murine CNS demyelinating disease caused by a coronavirus.

1 reference

12 December 2020

Patterns of oligodendroglia pathology in multiple sclerosis

1 reference

12 December 2020

Theiler's virus growth in murine macrophage cell lines depends on the state of differentiation

1 reference

12 December 2020

Deep gray matter T2 hypointensity correlates with disability in a murine model of MS.

1 reference

12 December 2020

Central nervous system pathology caused by autoreactive CD8+ T-cell clones following virus infection

1 reference

12 December 2020

Virus-induced demyelination in mice: "dying back" of oligodendrocytes

1 reference

12 December 2020

Theiler's Virus-Induced Demyelination: Prevention by Immunosuppression

1 reference

12 December 2020

Association of innate immune activation with latent Epstein-Barr virus in active MS lesions.

1 reference

12 December 2020

Axonal transection in the lesions of multiple sclerosis

1 reference

12 December 2020

MHV infection of the CNS: mechanisms of immune-mediated control.

1 reference

12 December 2020

A recombinant human IgM promotes myelin repair after a single, very low dose

1 reference

12 December 2020

IFN-gamma production and astrocyte recognition by autoreactive T cells induced by Theiler's virus infection: role of viral strains and capsid proteins.

1 reference

12 December 2020

The pathogenesis of murine coronavirus infection of the central nervous system

1 reference

12 December 2020

Apoptotic cells, including macrophages, are prominent in Theiler's virus-induced inflammatory, demyelinating lesions

1 reference

12 December 2020

Detection of Cellular Hypersensitivity among Multiple Sclerosis (MS) Patients to 6/94 Virus; a Parainfluenza Type 1 Isolate from MS Brain Tissue

1 reference

12 December 2020

Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS

1 reference

12 December 2020

SPONTANEOUS ENCEPHALOMYELITIS OF MICE--A NEW VIRUS DISEASE.

1 reference

12 December 2020

Method of identifying natural antibodies for remyelination.

1 reference

12 December 2020

The PI capsid region of Theiler's virus controls replication in mouse glial cell cultures

1 reference

12 December 2020

Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis

1 reference

12 December 2020

Statins--treatment option for central nervous system autoimmune disease?

1 reference

12 December 2020

Review of the morphological aspects of remyelination

1 reference

12 December 2020

Spontaneous and induced remyelination in multiple sclerosis and the Theiler's virus model of central nervous system demyelination

1 reference

12 December 2020

Development of postinfection epilepsy after Theiler's virus infection of C57BL/6 mice

1 reference

12 December 2020

The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice

1 reference

12 December 2020

The potential for oligodendrocyte proliferation during demyelinating disease.

1 reference

12 December 2020

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

1 reference

12 December 2020

1 reference

12 December 2020

Pro-inflammatory functions of astrocytes correlate with viral clearance and strain-dependent protection from TMEV-induced demyelinating disease

1 reference

12 December 2020

Release of myelin basic protein-degrading proteolytic activity from microglia and macrophages after infection with Theiler's murine encephalomyelitis virus: comparison between susceptible and resistant mice

1 reference

12 December 2020

Cortical lesions and brain atrophy in MS.

1 reference

12 December 2020

Monoclonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler's virus-infected mice: critical importance of timing of treatment

1 reference

12 December 2020

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

1 reference

12 December 2020

The distribution of plaques in the cerebrum in multiple sclerosis

1 reference

12 December 2020

Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group

1 reference

12 December 2020

Mechanism of Theiler's virus-induced demyelination in nude mice

1 reference

12 December 2020

Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA.

1 reference

12 December 2020

Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV).

1 reference

12 December 2020

Herpes simplex virus ICP0 and ICP4 immediate early proteins strongly enhance expression of a retrovirus harboured by a leptomeningeal cell line from a patient with multiple sclerosis

1 reference

12 December 2020

Regeneration and repair in multiple sclerosis: the view of experimental pathology

1 reference

12 December 2020

Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: When can axonal injury be beneficial?

1 reference

12 December 2020

Murine coronavirus-induced oligodendrocyte apoptosis is mediated through the activation of the Fas signaling pathway

1 reference

12 December 2020

Environment-gene interaction in multiple sclerosis: human herpesvirus 6 and MHC2TA

1 reference

12 December 2020

Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading

1 reference

12 December 2020

Long-term human coronavirus-myelin cross-reactive T-cell clones derived from multiple sclerosis patients

1 reference

12 December 2020

An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis

1 reference

12 December 2020

Limited remyelination in Theiler's murine encephalomyelitis due to insufficient oligodendroglial differentiation of nerve/glial antigen 2 (NG2)-positive putative oligodendroglial progenitor cells

1 reference

12 December 2020

Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group

1 reference

12 December 2020

CD4 T-cell-mediated demyelination is increased in the absence of gamma interferon in mice infected with mouse hepatitis virus

1 reference

12 December 2020

Hematopoietic cell activation in the subventricular zone after Theiler's virus infection

1 reference

12 December 2020

Role of macrophages during Theiler's virus infection

1 reference

12 December 2020

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212

1 reference

12 December 2020

Immunosuppression promotes CNS remyelination in chronic virus‐induced demyelinating disease

1 reference

12 December 2020

Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice

1 reference

12 December 2020

The innate immune response affects the development of the autoimmune response in Theiler's virus-induced demyelinating disease

1 reference

12 December 2020

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.

1 reference

12 December 2020

Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis

1 reference

12 December 2020

Persistent infection of oligodendrocytes in Theiler's virus‐induced encephalomyelitis

1 reference

12 December 2020

Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice

1 reference

12 December 2020

Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis

1 reference

12 December 2020

The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease.

1 reference

12 December 2020

Pathogenesis of multiple sclerosis--the immune diathesis and the role of viruses.

1 reference

12 December 2020

Spanish consensus on the use of natalizumab (Tysabri(®))--2011.

1 reference

12 December 2020

The pathologic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: implications for multiple sclerosis

1 reference

12 December 2020

CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination.

1 reference

12 December 2020

Pemyelination in relation to clinical lesions of the central nervous system

1 reference

12 December 2020

Epidemiologic evidence for multiple sclerosis as an infection

1 reference

12 December 2020

Macrophage infiltration, but not apoptosis, is correlated with immune-mediated demyelination following murine infection with a neurotropic coronavirus.

1 reference

12 December 2020

Differences in avidity and epitope recognition of CD8(+) T cells infiltrating the central nervous systems of SJL/J mice infected with BeAn and DA strains of Theiler's murine encephalomyelitis virus

1 reference

12 December 2020

Genetic deletion of a single immunodominant T-cell response confers susceptibility to virus-induced demyelination.

1 reference

12 December 2020

Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theiler's virus infection.

1 reference

12 December 2020

Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis

1 reference

12 December 2020

The role of CD8(+) T cells in multiple sclerosis and its animal models

1 reference

12 December 2020

Remyelination by oligodendrocytes stimulated by antiserum to spinal cord

1 reference

12 December 2020

The relation between inflammation and neurodegeneration in multiple sclerosis brains.

1 reference

12 December 2020

Cellular mechanisms of central nervous system repair by natural autoreactive monoclonal antibodies

1 reference

12 December 2020

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

1 reference

12 December 2020

Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors.

1 reference

12 December 2020

Oligodendrocytes in the early course of multiple sclerosis

1 reference

12 December 2020

Observations on encephalomyelitis of mice (DA strain)

1 reference

12 December 2020

Short-term treatment with interferon-alpha/beta promotes remyelination, whereas long-term treatment aggravates demyelination in a murine model of multiple sclerosis

1 reference

12 December 2020

The L-coding region of the DA strain of Theiler's murine encephalomyelitis virus causes dysfunction and death of myelin-synthesizing cells

1 reference

12 December 2020

The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system

1 reference

12 December 2020

Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits?

1 reference

12 December 2020

Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease

1 reference

12 December 2020

Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments

1 reference

12 December 2020

Absence of spontaneous central nervous system remyelination in class II-deficient mice infected with Theiler's virus.

1 reference

12 December 2020

Contrasting potential of nitric oxide and peroxynitrite to mediate oligodendrocyte injury in multiple sclerosis

1 reference

12 December 2020

Influence of sex on susceptibility in the Theiler's murine encephalomyelitis virus model for multiple sclerosis

1 reference

12 December 2020

Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody

1 reference

12 December 2020

The value of animal models for drug development in multiple sclerosis.

1 reference

12 December 2020

Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease.

1 reference

12 December 2020

Semliki Forest virus-induced demyelination and remyelination--involvement of B cells and anti-myelin antibodies

1 reference

12 December 2020

The link between excitotoxic oligodendroglial death and demyelinating diseases

1 reference

12 December 2020

A critical role for virus-specific CD8(+) CTLs in protection from Theiler's virus-induced demyelination in disease-susceptible SJL mice

1 reference

12 December 2020

Viral pathogens in multiple sclerosis: an intriguing (hi)story

1 reference

12 December 2020

Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs

1 reference

12 December 2020

Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis

1 reference

12 December 2020

Theiler's virus infection: a model for multiple sclerosis

1 reference

12 December 2020

Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler's virus-induced demyelinating disease model of multiple sclerosis

1 reference

12 December 2020

Targeting of IgMkappa antibodies to oligodendrocytes promotes CNS remyelination.

1 reference

12 December 2020

Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus

1 reference

12 December 2020

Kallikrein 6 regulates early CNS demyelination in a viral model of multiple sclerosis

1 reference

12 December 2020

IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome

1 reference

12 December 2020

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

1 reference

12 December 2020

Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis

1 reference

12 December 2020

Absence of perforin expression confers axonal protection despite demyelination.

1 reference

12 December 2020

The origin and application of experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

12 December 2020

Environmental risk factors for multiple sclerosis. Part I: The role of infection

1 reference

12 December 2020

In vivo depletion of CD8+ T cells prevents lesions of demyelination in Semliki Forest virus infection

1 reference

12 December 2020

Coronavirus infection of the central nervous system: host-virus stand-off

1 reference

12 December 2020

A virus-induced molecular mimicry model of multiple sclerosis

1 reference

12 December 2020

Current disease-modifying therapies in multiple sclerosis

1 reference

12 December 2020

Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection

1 reference

12 December 2020

Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination

1 reference

12 December 2020

Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death

1 reference

12 December 2020

Multiple sclerosis: an immune or neurodegenerative disorder?

1 reference

12 December 2020

Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation

1 reference

12 December 2020

Plaque-associated expression of human herpesvirus 6 in multiple sclerosis

1 reference

12 December 2020

Deletion of beta-2-microglobulin ameliorates spinal cord lesion load and promotes recovery of brainstem NAA levels in a murine model of multiple sclerosis

1 reference

12 December 2020

Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus

1 reference

12 December 2020

Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis

1 reference

12 December 2020

Invited article: human natural autoantibodies in the treatment of neurologic disease

1 reference

12 December 2020

Transgenic expression of viral capsid proteins predisposes to axonal injury in a murine model of multiple sclerosis

1 reference

12 December 2020

Serum and CSF measles antibody levels increase over time in patients with multiple sclerosis or clinically isolated syndrome

1 reference

12 December 2020

Suggesting the possible role of Turkey Herpesvirus or HVT-like as a predisposing factor or causative agent in multiple sclerosis

1 reference

12 December 2020

Alphavirus-induced encephalomyelitis: antibody-secreting cells and viral clearance from the nervous system

1 reference

12 December 2020

GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Schwann cell remyelination and recurrent demyelination in the central nervous system of mice infected with attenuated Theiler's virus.

1 reference

12 December 2020

Theiler's virus infection induces a predominant pathogenic CD4+ T cell response to RNA polymerase in susceptible SJL/J mice

1 reference

12 December 2020

Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T.

1 reference

12 December 2020

Clearance of Theiler's virus infection depends on the ability to generate a CD8+ T cell response against a single immunodominant viral peptide

1 reference

12 December 2020

Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.

1 reference

12 December 2020

Evolution of mouse hepatitis virus (MHV) during chronic infection: quasispecies nature of the persisting MHV RNA.

1 reference

12 December 2020

Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration.

1 reference

12 December 2020

Inflammatory cortical demyelination in early multiple sclerosis

1 reference

12 December 2020

Intrathecal human herpesvirus 6 antibodies in multiple sclerosis and other demyelinating diseases presenting as oligoclonal bands in cerebrospinal fluid

1 reference

12 December 2020

Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis

1 reference

12 December 2020

Differentiation of M1 myeloid precursor cells into macrophages results in binding and infection by Theiler's murine encephalomyelitis virus and apoptosis

1 reference

12 December 2020

Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis

1 reference

12 December 2020

Primary demyelination in Theiler's virus infection. An ultrastructural study

1 reference

12 December 2020

Human herpesvirus 6 and multiple sclerosis: systemic active infections in patients with early disease

1 reference

12 December 2020

Relationship between host age and persistence of Theiler's virus in the central nervous system of mice

1 reference

12 December 2020

Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes

1 reference

12 December 2020

Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region

1 reference

12 December 2020

Quantitative ultrastructural analysis of a single spinal cord demyelinated lesion predicts total lesion load, axonal loss, and neurological dysfunction in a murine model of multiple sclerosis

1 reference

12 December 2020

Failure of treatment with Linomide or oral myelin tolerization to ameliorate demyelination in a viral model of multiple sclerosis

1 reference

12 December 2020

Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis

1 reference

12 December 2020

Transgenic expression of Theiler's murine encephalomyelitis virus genes in H-2(b) mice inhibits resistance to virus-induced demyelination

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

Semliki Forest virus-induced, immune-mediated demyelination: adoptive transfer studies and viral persistence in nude mice

1 reference

12 December 2020

The T lymphocyte in experimental allergic encephalomyelitis

1 reference

12 December 2020

Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis

1 reference

12 December 2020

Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction

1 reference

12 December 2020

Why does remyelination fail in multiple sclerosis?

1 reference

12 December 2020

Glutamate excitotoxicity in a model of multiple sclerosis

1 reference

12 December 2020

B cells and antibodies in the pathogenesis of myelin injury in Semliki Forest Virus encephalomyelitis

1 reference

12 December 2020

The role of antigen presenting cells in multiple sclerosis

1 reference

12 December 2020

Experimental demyelination produced by the A59 strain of mouse hepatitis virus

1 reference

12 December 2020

Axonal injury heralds virus-induced demyelination.

1 reference

12 December 2020

Pathogenesis of Theiler's murine encephalomyelitis virus

1 reference

12 December 2020

Antiviral immune responses modulate the nature of central nervous system (CNS) disease in a murine model of multiple sclerosis

1 reference

12 December 2020

Therapeutic action of cannabinoids in a murine model of multiple sclerosis.

1 reference

12 December 2020

The genetics of the persistent infection and demyelinating disease caused by Theiler's virus

1 reference

12 December 2020

Oligodendrocyte-reactive O1, O4, and HNK-1 monoclonal antibodies are encoded by germline immunoglobulin genes

1 reference

12 December 2020

CD8+ T cells directed against a viral peptide contribute to loss of motor function by disrupting axonal transport in a viral model of fulminant demyelination

1 reference

12 December 2020

Effect of cyclosporin A, silica quartz dust, and protease inhibitors on virus-induced demyelination

1 reference

12 December 2020

Myelin-specific tolerance attenuates the progression of a virus-induced demyelinating disease: implications for the treatment of MS.

1 reference

12 December 2020

1 reference

12 December 2020

Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury

1 reference

12 December 2020

Replication of the A7(74) strain of Semliki Forest virus is restricted in neurons

1 reference

12 December 2020

Phosphorylation of U24 from Human Herpes Virus type 6 (HHV-6) and its potential role in mimicking myelin basic protein (MBP) in multiple sclerosis

1 reference

12 December 2020

Inside-Out versus Outside-In models for virus induced demyelination: axonal damage triggering demyelination

1 reference

12 December 2020

CD4(+) and CD8(+) T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis

1 reference

12 December 2020

A study of measles virus and canine distemper virus antibodies, and of childhood infections in multiple sclerosis patients and controls

1 reference

12 December 2020

HTLV-1 infection and the viral etiology of multiple sclerosis

1 reference

12 December 2020

Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair

1 reference

12 December 2020

Extensive hippocampal demyelination in multiple sclerosis

1 reference

12 December 2020

Brain atrophy correlates with functional outcome in a murine model of multiple sclerosis

1 reference

12 December 2020

Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial

1 reference

12 December 2020

Neuron-binding human monoclonal antibodies support central nervous system neurite extension

1 reference

12 December 2020

Measles- or mumps virus-infected cells forming rosettes with lymphocytes from patients with multiple sclerosis

1 reference

12 December 2020

Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Selective localization of wild type and mutant mouse hepatitis virus (JHM strain) antigens in CNS tissue by fluorescence, light and electron microscopy

1 reference

12 December 2020

Does Simian Virus 5 Infect Humans?

1 reference

12 December 2020

Epstein-Barr virus and multiple sclerosis

1 reference

12 December 2020

Theiler's Murine Encephalomyelitis Virus (TMEV)-Induced Demyelination: A Model for Human Multiple Sclerosis

1 reference

12 December 2020

CD8+ T cells cause disability and axon loss in a mouse model of multiple sclerosis

1 reference

12 December 2020

Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation

1 reference

12 December 2020

Anti-adhesion molecule therapy in Theiler's murine encephalomyelitis virus-induced demyelinating disease

1 reference

12 December 2020

Remyelination during remission in Theiler's virus infection

1 reference

12 December 2020

Induction of autoreactive CD8+ cytotoxic T cells during Theiler's murine encephalomyelitis virus infection: implications for autoimmunity.

1 reference

12 December 2020

Demyelinated axons and motor function are protected by genetic deletion of perforin in a mouse model of multiple sclerosis

1 reference

12 December 2020

Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction

1 reference

12 December 2020

10.1016/J.PNEUROBIO.2012.11.003

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23201558%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

PMC publication ID

7117056

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23201558%20AND%20SRC:MED&resulttype=core&format=json